Why is Global Personal Protective Equipment Market Booming? The global personal protective equipment market is predicted to exhibit huge expansion in the coming years, as per the estimates of P&S Intelligence, a market research company based in India. The implementation of strict regulations regarding occupational safety and health is one of the biggest factors responsible for the advancement of the market. The growing public awareness of personal safety at workplaces is another major factor driving the progress of the market. Due to the surging incidence of workplace accidents and fatalities, many companies all over the world are focusing heavily on employee safety. These equipment include gear that can protect the face, eye, head, legs, feet, arms, and hands. These products protect people from various accidents such as those involving the falling of items, collision with sharp objects and edges, flying sparks, and chemical hazards. The Occupational Safety and Health Administration (OSHA) has laid down various codes of regulations (CFR).

According to these regulations, employers are liable to protect their employees from various workplace hazards and fatalities. The prominent CFR include face and eye protection, foot protection, head protection, hand protection, and electrical protective equipment. The non-compliance of these codes and policies attract massive penalties and fines for the employers. The prevalent certifications and regulations regarding the protection of employees at workplaces are issued by the American National Standards Institute (ANSI), CSA Group, and OSHA. Moreover, with the outbreak of the COVID-19 pandemic, the demand for personal protective equipment (PPE) is rising rapidly across the globe. This is because these devices play a major role in mitigating the spread of the infection. Depending on industry type, the personal protective equipment market is divided into manufacturing, oil and gas, chemical and pharmaceutical, food and beverage, transportation, and construction. Amongst these, the transportation industry will register huge growth in the market in the future years. When product is taken into consideration, the personal protective equipment market is classified into respiratory protection, hand protection, head, eye, and face protection, hearing protection, fall protection, and protective clothing. Amongst these, the respiratory protection category is currently exhibiting rapid growth and is predicted to hold a considerably high share in the market in the future. The rising prevalence of respiratory and communicable diseases such as bird flue and H1N1 are the main factors driving the expansion of this category. Across the globe, the personal protective equipment market is demonstrating huge growth in the U.S. In Europe, the industry is expanding rapidly in the U.K., Russia, France, and Germany. India, Japan, and China are the major markets in the Asia-Pacific (APAC) region. The rapid industrialization in the APAC region, on account of the soaring population levels, is predicted to massively propel the growth of the market in the coming years.

How is Increasing Geriatric Population in Region Driving North American Defibrillators Market? Aging is among those few aspects of life upon which human being have no control at all, despite of all the technological advancements. In scientific terms, aging is the impact of the accumulation of an extensive range of molecular and cellular damage over time, which results in gradual decrease in mental and physical capacity, a rising risk of disease, and ultimately, death. Some of the common conditions by which aged people suffer include beck & neck pain and osteoarthritis, hearing loss, chronic obstructive pulmonary diseases, dementia, diabetes, and cataracts and refractive errors. More often than not, aged people are likely to suffer from multiple conditions at once.

The geriatric population is increasing across the globe, including North America. In 2017, the number of people aged 60 years or above in North America was 79 million, and this number is further predicted to increase to 123 million in 2050. It has already been established the aged population is susceptible to suffering from heart conditions, the treatment process often creates need for defibrillators, which restore the normal heartbeat by sending an electric shock to the heart. These devices are utilized for preventing or correcting an arrhythmia and also for restoring the heart’s beating if it stops suddenly.

Browse detailed report on North American Defibrillators Market Size, and Business Strategies Thus, due to the rising geriatric population in North America, the demand for defibrillators is also growing. As per a P&S Intelligence report, in 2017, the North American defibrillators market attained a value of $6.1 billion and is projected to generate a revenue of $8.1 billion by 2023, advancing at a 4.9% CAGR during the forecast period (2018–2023). The two types of defibrillators, external and implantable cardioverter defibrillators, are further classified into automated, wearable cardioverter, and manual and transvenous implantable cardioverter and subcutaneous implantable cardioverter, respectively. These different types of defibrillators are used in home care settings, hospitals, clinics, & cardiac centers, pre-hospital settings, and public access settings. Within the region, the demand for defibrillators is expected to increase inconsiderably in Canada, which is ascribed to the prising government support in the form of initiatives and funding in order to increase the awareness among people and provide efficient training on defibrillation. Apart from this, a large number of local suppliers for defibrillators are present in the country and the surging number of spinocerebellar ataxia cases are also contributing significantly to the growth of the North American defibrillators market. Hence, the demand for defibrillators in North America is growing because of the surging geriatric population and technological advancements.

The prevalence of obstructive sleep apnea (OSA) has risen considerably over the past few years. OSA is a serious sleep disorder and causes the breathing to stop and start during sleep. This disease is a type of sleep apnea and occurs when muscles of the throat relax intermittently and block the airway while sleeping. Some of the major symptoms of OSA include, loud snoring, excessive daytime sleepiness, abrupt awakenings accompanied by choking or gasping, morning headache, and observed episodes of stopped breathing during sleep. Attributed to this growing prevalence of OSA, the need for sleep apnea devices is growing rapidly.

As per a report by P&S Intelligence, the global sleep apnea devices market is predicted to attain a value of $6.8 billion by 2023, rising from $4.4 billion in 2017, and is expected to advance at a 7.7% CAGR during the forecast period (2018–2023). Sleep apnea devices are of two types therapeutic and diagnostic, between which, the demand for therapeutic sleep apnea devices was higher in the past, and these devices are further predicted to be more in demand in the coming years as well. This is majorly due to the rising prevalence of OSA, which, in turn, is resulting in the increasing need for positive airway pressure (PAP) devices and adoption of technological innovative products. Different types of therapeutic sleep apnea devices are adaptive servo-ventilators, PAP devices, oral appliances, and facial interfaces. Out of these, the demand for different PAP devices was considerably high, since they provide effective medication benefits as compared to other sleep apnea devices. Types of diagnostic sleep apnea devices are home sleep testing devices, polysomnography devices, sleep screening devices, respiratory polygraphs, actigraphy devices, and pulse oximeters. Geographically, North America emerged as the largest sleep apnea devices market in the past, which can be on account of the increasing investments by public and private organizations, increasing research and development activities, and surging incidence of sleep disorders and associated health conditions, including heart diseases and obesity. Apart from this, the demand for sleep apnea devices is also projected to grow considerably in Asia-Pacific in the years to come. This can be attributed to the increasing prevalence of OSA, radical changes in the lifestyles of people, changing sleep patterns, and rising work related stress in the region. In conclusion, the demand for sleep apnea devices is growing due to the increasing prevalence of OSA, rising investments, surging awareness regarding this diseases, and changing lifestyle.

The rising incidence of anaphylaxis, increasing prevalence of multiple sclerosis, surging geriatric population, and rapid production of biologic products are the main factors pushing up the demand for auto-injectors across the world. In addition, the soaring healthcare spending in several countries and the growing public awareness about the various beneficial traits of auto-injectors are also contributing toward their booming sales. Auto-injectors are basically pen like medical instruments that are used for administering a specified dose of drugs into the body.

Browse report with detailed COVID-19 impact analysis on Auto-Injectors Market Size, and Demand Forecast

They consist of spring-loaded syringes that are particularly built for ensuring the safe administration of drugs into the body. These instruments have various added beneficial traits such as greater user-friendliness, which reduces the requirement for frequent visits to medical practitioners. Due to these factors, the popularity of these devices is growing rapidly, which is, in turn, driving the growth of the global auto-injectors market. Fillable and prefilled are the two major types of auto-injectors used across the world. This is achieved by using automated pathways, that considerably reduce the chances of dose errors and accidental injuries. These devices are extensively used for treating multiple sclerosis, anaphylaxis, and rheumatoid arthritis. Out of these, the requirement for these devices was the highest in the treatment of anaphylaxis in the years gone by, as per the observations of the market research firm, P&S Intelligence. This was because of the widespread occurrence of this disease. Europe also witnessed huge sales of these devices in the past years. In this continent, the demand for these products was the highest in the U.K., followed by Germany and France. On the other hand, the sales of these devices are predicted to soar in Asia-Pacific (APAC) in the forthcoming years, mainly because of the growing public awareness about the various needle-stick injuries in the region. The demand for auto-injectors will also surge in Europe in the years to come. Thus, it can be said with certainty that the demand for auto-injectors will shoot up in the future, on account of the growing incidence of anaphylaxis and diabetes, the surging population of ageing people, and rising public awareness about safer drug administration methods across the world.

A number of factors, such as the rising incidence of chronic illnesses and lifestyle-associated diseases, growing aging population, improving healthcare infrastructure, surging need for minimally invasive procedures, technological advancements, and rising disposable income of people, are projected to propel the growth of the medical electrodes market at a CAGR of 6.7% during the forecast period (2021–2025). According to P&S Intelligence, the market generated $842.9 million revenue in 2020, which is expected to reach $1,151.6 million by 2025. Moreover, the market is witnessing a trend of surging launches of new and improved medical electrodes. The usability segment of the medical electrodes industry is classified into disposable and reusable. Between the two, the disposable category accounted for the larger market share in 2020, and it is projected to record faster growth in the coming years. This can be ascribed to the surging need for disposable electrodes, as these are easy to use and are of low cost. Moreover, these have low preparation time for usage, inferior risk of cross-contamination among patients, and not required sterilization beforehand usage, and are available as dry-surface or pre-gelled electrodes. Geographically, North America held the largest share in the medical electrodes market in 2020. This is attributed to the growing geriatric population, technological developments, and advanced healthcare industry in the region. The elderly population needs primary diagnosis of neurological diseases and CVDs for the timely and efficient treatment. For instance, as per the World Population Ageing 2019 report, published by the United Nations, the regional population aged 65 years and older stood at 59.9 million in 2019, and it is projected to reach 96.3 million by 2050. Thus, the rising incidence of chronic illnesses and lifestyle-associated diseases and the surging aging population are expected to propel the demand for medical electrodes during the forecast period.

The high prevalence of chronic diseases, burgeoning requirement for chemotherapy procedures, growing use of radial access devices on geriatric and high-risk patients, and surging healthcare expenditure are the key transradial access devices market growth drivers. The transradial approach benefits from low cost and favorable clinical outcomes over transfemoral interventions; therefore, it can help in reducing the healthcare expense for patients, especially in developing countries. Thus, with the growing volume of catheterization procedures, the demand for the devices used for accessing the targeted tissue via the radial artery will increase. Various studies have been conducted to determine the benefits of using the transradial approach for transarterial chemoembolization in cancer patients. The favorable results of these studies are boosting the preference for this approach, thereby propelling the growth of the transradial access devices market. Those with peripheral vascular diseases, patients on oral anticoagulants who have a high risk of vascular access site bleeding, elderly patients, and morbidly obese patients are treated by snaking a catheter to the targeted therapy site via the radial artery, which runs through the arm. In this regard, the growing volume of embolotherapy procedures can be considered a key transradial access devices market growth driver. Such procedures are widely conducted for the treatment of cancer, arteriovenous malformations, cerebral aneurysms, and gastroenterological, nephrological, and urological disorders. They involve administering an embolic agent to the targeted tissue in order to cut its blood supply and lead to cell death. Moreover, microspheres can be placed at the targeted tissue via transradial catheterization to inject drugs. Geographically, Europe contributed the highest revenue to the transradial access devices market in the past. This was due to the wide acceptance of transradial intervention (TRI) as the default strategy for percutaneous coronary interventions (PCI) in Europe. Moreover, the U.S., Canada, China, India, and Japan are expected to create a high demand for transradial access devices in the coming years. The advancing healthcare infrastructure and rising awareness among various healthcare providers regarding the benefits of the transradial approach over the transfemoral approach are propelling the market. Therefore, the demand for transradial access devices will increase due to the changing preferences of healthcare providers and increasing prevalence of chronic diseases globally.

The global medical lasers market generated a revenue of $5.1 billion in 2016, and it is predicted to advance at a CAGR of 13.4% between 2017 and 2023. Furthermore, the market will reach a value of $12.1 billion by 2023, as per the estimates of the market research firm, P&S Intelligence. The factors driving the market expansion are the burgeoning requirement for medical lasers for treating various diseases, mushrooming demand for non-invasive treatments, and increasing number of aesthetic procedures. Additionally, the rapid technological advancements being made in laser are also fueling its popularity in the medical industry. These advancements in the laser technology have fueled various benefits such as reduction in pain intensity, quick recovery after cosmetic or surgical procedures, and small incisions. Moreover, due to these innovations and advancements, the application of laser in several cosmetic treatments such as skin rejuvenation, body contouring, and hair removal has increased massively.

Read More Medical Lasers Market Size and Demand Forecast Report In addition, the advent of small hand-held diode lasers has made laser devices very advanced. Besides these factors, the growing incidence of skin and chronic diseases and the surging population of geriatric people in several countries are also driving the growth of the medical lasers market. As old age causes the loss of fibrous tissue and reduced glandular and vascular network in skin layers, geriatric people are highly vulnerable to pigmentary alteration, skin sagging, wrinkles, and dryness. Out of these, the Nd:YAG systems sub-category contributed huge revenue to the market in the past years. Across the globe, the medical lasers market is predicted to demonstrate the highest growth rate in the Asia-Pacific (APAC) region in the forthcoming years. This is credited to the surging healthcare expenditure, flourishing medical tourism industry, soaring popularity of cosmetic treatments, and the growing public awareness about technologically advanced laser treatments in the region. Hence, it can be said without any hesitation that the market will exhibit huge expansion in the upcoming years, primarily because of the rising requirement for cosmetic and skin treatment procedures, the growing incidence of skin diseases, and the surging geriatric population all over the world.

The European Commission reveals that the mean and median income of the people of Denmark, Germany, Spain, and France increased from 30,104 Euro in 2018 to 30,717 Euro in 2019, 22,713 Euro in 2018 to 23,515 Euro in 2019, 14,785 Euro in 2018 to 15,015 Euro in 2019, and 22,220 Euro in 2018 to 22,562 Euro in 2019, respectively. Likewise, the Bureau of Economic Analysis (BEA) states that the personal income of the people of the U.S. surged from $19,777.4 in the third quarter (Q3) of 2020 to $20,797.8 in Q3 of 2021. The surging personal income will augment the purchasing power of people, owing to which the dermacosmetics market will showcase a CAGR of 7.3% during 2020–2030. The market was valued at $57.0 billion in 2020 and it is projected to generate $115.2 billion revenue by 2030. In contemporary years, high income is encouraging more people to spend on dermacosmetic products and treatments. The mounting public focus on physical appearance will increase the footfall of such people in hospitals and clinics, medical spas, and salons that offer skincare and haircare treatments. Skincare products, such as cleanser, cream, gel, lotion, serum, and toner, and haircare products, such as conditioner and shampoo, are being used by people around the world to improve their physical appearance. In contemporary times, skincare products were consumed in higher volume due to the soaring public focus on acne treatment, skin whitening, spot removal, and anti-aging sign reduction. All these dermacosmetic products are available at online channels and pharmacies and retail stores. According to P&S Intelligence, the European region has emerged as the leader of the dermacosmetics market over the last few years, owing to the surging incidence of skin disorders and rising public awareness about skincare products in the region. For instance, the British Skin Foundation estimates that nearly 60% of the people in the U.K. suffer from skin disorders at some point in their lifetime, and approximately 70% of the British populace have visible skin conditions or scars.

Currently, the world is witnessing a surge in the incidence of chronic illnesses like diabetes, stroke, cancer, heart diseases, and respiratory ailments, mainly on account of lifestyle changes and lack of access to preventive care, especially in emerging economies. According to the Global Cancer Observatory (GLOBOCAN), the world recorded 19.3 million new cancer cases and 10 million cancer deaths in 2020. Further, the World Health Organization (WHO) estimates that nearly 17.9 million lives are lost due to cardiovascular diseases (CVDs) each year. Owing to the substantial rise in cases of chronic diseases will boost the usage of network connected medical devices, as these devices are used to monitor and manage the occurrence of such diseases. Moreover, improvement in healthcare infrastructure has also increased the penetration of such devices, worldwide. Due to such reasons, the network connected medical devices market will progress at a CAGR of 23.5% during 2019–2024. According to P&S Intelligence, the market was valued at $19.5 billion in 2018 and it is expected to reach $66.6 billion by 2024. Moreover, increasing participation of government associations and market players in the form of funding and promotion will boost the penetration of network connected medical devices in the coming years. For example, Caretaker Medical LLC, in May 2018, announced the completion of an investment of $3.4 million to accelerate the commercialization activities of wireless continuous non-invasive blood pressure (CNIBP) and vital signs monitors, which are approved by the Food and Drug Administration (FDA). Additionally, the surging number of collaborations and partnerships among key market players will also fuel the adoption of such devices, globally. Geographically, the North American network connected medical devices market will witness the highest growth rate in the foreseeable future. This will be due to the continuous technological developments and high adoption of technologically improved medical products in the region. Moreover, the growth of the medical devices industry, on account of increasing research activities, will accelerate the sales of network connected medical devices in the coming years. Besides, huge funding from private and government entities will also boost the usage of such devices in North America. Thus, the surging cases of cancer, CVDs, diabetes, and respiratory diseases will accelerate the procurement of network connected medical devices in the coming years.

Market Overview@ Network Connected Medical Devices Market Trend Analysis, and Growth Status

According to the World Health Organization (WHO), cardiovascular diseases (CVDs) are the topmost cause of global deaths. The organization estimates that this disease causes nearly 17.9 million deaths each year. Four out of five CVD deaths occur due to strokes and heart attacks and nearly one-third of these deaths occur prematurely among people under 70 years of age. Furthermore, the organization also states that cancer accounted for nearly 10 million deaths in 2020. Cancer is a prominent cause of death worldwide. Due to the surging cases of such chronic ailments, the requirement for endoscopes is surging exponentially.

Nowadays, medical device manufacturers are focusing on curtailing the production cost by relocating their production units to areas with cheap raw materials and labor. Moreover, the tax relaxations and incentives offered by the governments of several emerging economies are encouraging these manufacturers to shift their manufacturing base from developed nations to developing countries. For example, in 2017, the National Health and Family Planning Commission (NHFPC) of China implemented an incentive scheme for medical device manufacturers to attract overseas companies to the country. According to P&S Intelligence, North America is the largest consumer of endoscopes, due to the rapid technological advancements, presence of a large number of hospitals, existence of leading medical device manufacturers, high prevalence of chronic diseases, improved healthcare infrastructure, and vast geriatric population in the region. In North America, the U.S. adopts the larger volume of endoscopes, owing to the rising cases of gastrointestinal and respiratory diseases, soaring number of hospitals, and burgeoning geriatric population in the country. According to the National Heart, Lung, and Blood Institute, more than 16 million people in the U.S. are affected by the chronic obstructive pulmonary disease (COPD). Thus, the increasing incidence of chronic diseases and rapid technological advancements being made in the medical devices industry will augment the usage of endoscopes in the coming years.

The World Health Organization (WHO) estimates that at any given time, of every 100 hospitalized patients, around 10 in developing countries and 7 in developed countries acquire at least one healthcare-associated infection (HAI). As compared to high-income countries, the burden of HAIs is higher in low- and middle-income countries, especially in patients admitted to intensive care units (ICUs), owing to the poor conditions of healthcare facilities in these nations. Thus, the surging incidence of HAIs is propelling the usage of medical disposables, worldwide.

In addition, the soaring geriatric population will also help the medical disposables market prosper during 2021–2030. The market was valued at around $51 billion in 2020 and it is projected to generate about $90 billion revenue by 2030. According to the United Nations Department of Economic and Social Affairs (UNDESA), the population of people aged 65 years and more will rise from 727 million in 2020 to 1.5 billion by 2050. Old people require long-term hospital care because they take a longer time to overcome chronic ailments such as cancer, cardiovascular diseases (CVDs), and kidney failures. Moreover, increasing technological advancement in medical supplies for homecare settings is also fueling the consumption of medical disposables across the world. Nowadays, leading manufacturers of medical disposables are focusing on expanding their product portfolio by integrating advanced technologies in their offerings. At present, single-use or disposable medical devices are economically viable than cost-effective reusable medical supplies. The usage of disposable medical products and devices help in preventing the spread of infection and avoiding the complex and labor-intensive process of reusing the supplies. All these medical disposables are used in hospitals, research institutes, ambulatory surgery centers, assisted living centers and nursing homes, and clinics/physician offices for diagnosing diseases and treating chronic disease patients. In recent years, hospitals have been consuming the highest volume of medical disposables, due to the increasing patient footfall at such healthcare facilities, because they are equipped with state-of-the-art facilities and employ trained professionals across disciplines. As sterilization of reusable devices enhances the procedure cost, the hospitals are using disposable devices to curtail their operation costs. According to P&S Intelligence, North America led the medical disposables market in the preceding years, due to the rising aging population, surging government expenditure on research and development (R&D), and increasing prevalence of HAIs, in the region. For instance, the Centers for Disease Control and Prevention (CDC) estimates that on any given day, around 1 in 31 hospital patients in the U.S. has at least one HAI. Moreover, the mounting healthcare costs and growing prevalence of chronic diseases will also create a huge requirement for medical disposables in North America.

According to the World Health Organization (WHO), 41 million global deaths are caused due to non-communicable diseases (NCDs) annually. As per the organization, NCDs, such as cardiovascular diseases (CVDs), cancers, respiratory diseases, and diabetes, account for 17.9 million, 9.3 million, 4.1 million, and 1.5 million fatalities, respectively, each year. Furthermore, the WHO reveals that in 2019, 1.7 million people were infected by the human immunodeficiency virus (HIV), globally. It also estimates that 229 million cases of malaria were recorded in 2019, worldwide.

Moreover, the booming aging population will propel the deployment of centralized and decentralized automated dispensing machines in hospitals and pharmacies in the upcoming years. As aging weakens the immune system, older people become highly susceptible to illnesses. The United Nations Department of Economic and Social Affairs (UNDESA) predicts that the global population of people aged 65 years or more will increase from 727 million in 2020 to 1.5 billion by 2050. As the elderly population requires advanced care, their expanding population will create a massive requirement for such machines. At present, automated dispensing machine manufacturers, such as Becton, Dickinson and Company, B. Braun Melsungen AG, ScriptPro LLC, Swisslog Holding AG, TouchPoint Medical, Newlcon Oy, and Accu-Chart Plus Healthcare Systems Inc., are engaging in product launches to help improve medication compliance. For instance, in January 2020, TouchPoint Medical Inc. unveiled the next-generation medDispense series to deliver several dispensing options and security across one software platform. This machine supports bulk item storage, single-dose dispensing, and single-line-item control while using the medLogicTM software platform. Geographically, North America is expected to dominate the automated dispensing machines market in the future due to the surging geriatric population and improving healthcare infrastructure. For instance, according to the 2019 Profile of Older Americans published by the Administration for Community Living, operating under the U.S. Department of Health and Human Services, the population of people aged 65 years and above in the U.S. will surge from 52.4 million in 2018 to 94.7 million by 2060. Therefore, the rising prevalence of chronic diseases and the growing geriatric population will boost the adoption of automated dispensing machines.

How is Rising Prevalence of Chronic Diseases Fuelling Progress of Guidewires Market? Owing to the rising prevalence of chronic and lifestyle-associated diseases across the world, the demand for guidewires will boom in the coming years. A majority of the lifestyle-related diseases occur due to these behaviours- obesity, unhealthy diet, physical inactivity, and smoking. As per the obesity report published by the Organization of Economic Cooperation and Development (OECD) in 2015, 19.5% of the adult population was found to be obese across member countries. The obesity rate was less than 6% in the Japan and South Korea and as high as 30% in the U.S, Mexico, Hungary, and New Zealand.

The other major factor pushing the demand for guidewires, which are used while inserting a catheter into the body, is the increasing need for minimally invasive surgeries such as coronary guidewire treatment owing to the rising incidence of cardiovascular diseases in the developed nations. As per a report published by the European Association of Cardio-Thoracic Surgery (EACTS) in 2015, the demand for minimally invasive cardiac surgeries has increased rapidly over the last 10–15 years. As per Eurostat, the number of laparoscopic colectomy procedures per 100,000 people increased from 26.4 to 29.8 from 2010 to 2015. The major trends currently being observed in the guidewires market are the rising need for interventional procedures in the emerging economies and rapid advancements and innovations in guidewires throughout the world. Since the last few years, there has been a massive surge in the demand for coronary procedures in India. As per the data published in coronary interventional registry set up by the National Interventional Council (NIC), Cardiological Society of India, 177,240 Percutaneous Coronary Intervention (PCI) procedures were performed in the country in 2012. Moreover, there was a 16.4% growth in PCI procedures conducted in India from 2011 to 2012. Globally, the Asia-Pacific (APAC) region is expected to register the fastest growth in the usage of guidewires during the forecast period. The main factors responsible for this rapidly rising utilization of guidewires in APAC are the increasing incidence of chronic diseases and lifestyle-related disorders, soaring medical tourism, and rapidly improving healthcare infrastructure in the region. As per the International Diabetes Federation Atlas, India and China are amongst the top two nations in the world with the largest number of diabetic patients in the age group of 20–79 years. Hence, it can be concluded that due to the increasing occurrence of chronic and lifestyle-related diseases and the burgeoning need for minimally invasive surgical procedures across the world, the demand for guidewires will surge in the coming years.

According to the International Diabetes Federation (IDF) Diabetes Atlas Ninth edition 2019, approximately 700 million people within the age group of 20–79 years will be living with diabetes by 2045. The report also says that around 374 million people are at an increased risk of developing type 2 diabetes. Furthermore, the World Health Organization (WHO) states that cancer caused around 10 million deaths in 2020. The WHO also forecasts that by 2030, cardiovascular diseases (CVDs) related deaths will rise over 23.6 million. The increasing incidence of such chronic diseases is augmenting the need for diagnostic imaging systems.

As these diseases are highly prevalent among the elderly population, the booming geriatric population will fuel the diagnostic imaging systems market at a CAGR of 5.8% during 2020–2030. The market was valued at $38.9 billion in 2019 and it is projected to reach a revenue of $70.0 billion by 2030. As per the World Population Ageing 2019 report published by the United Nations (UN), the population of people aged 65 years or above will grow to 1.5 billion by 2050. Old people require extensive care, as they are highly susceptible to chronic illnesses, owing to their low immunity levels. Currently, diagnostic imaging systems manufacturers are focusing on producing X-ray imaging systems, owing to the extensive use of these systems in various medical application areas, such as dentistry, orthopedics, and cardiology. Whereas, in the coming years, manufacturers will be selling nuclear imaging systems at a rapid pace, due to the surging cases of cancer. These systems are being increasingly adopted for cancer staging and treatment. Additionally, manufacturers are also involved in the production of ultrasound systems, computed tomography (CT) scanners, and magnetic resonance imaging (MRI) systems. According to P&S Intelligence, North America dominated the diagnostic imaging systems market in the recent past, due to the surging incidence of chronic disorders and soaring healthcare expenditure in the region. Moreover, the presence of a large number of modern diagnostic centers and hospitals also augmented the use of such systems in North America. Whereas, Asia-Pacific (APAC) is expected to adopt these systems at the highest rate in the foreseeable future. This can be ascribed to the rising prevalence of chronic ailments and the booming number of diagnostic imaging centers across the region. Thus, the escalating cases of chronic diseases and booming geriatric population will augment the need for diagnostic imaging systems in the coming years.

On account of the changes in lifestyle, tobacco and alcohol abuse, environmental factors, and genetic predisposition, the prevalence of cancer and cardiovascular diseases (CVDs) is rising. As per the World Health Organization (WHO), around 9.6 million deaths in the world are caused due to cancer each year. The organization also states that CVDs account for more than 17.9 million deaths across the world. Surgeons use vascular imaging systems to detect such diseases, as these systems can diagnose blockages in the veins, varicose veins, weakening of the arteries and veins, plaque formation, and blood clots.

Old people undergo vascular imaging tests more than young people. The National Institutes of Health (NIH) states that in the U.S., people aged 65 years and above undergo these tests twice as compared to individuals within the age group of 30–59 years. Therefore, with a boom in the aging population, the volume of vascular imaging procedures will escalate in the coming years. According to the Department of Economic and Social Affairs of the United Nations, the global population of people aged 65 years and above will reach 1.5 billion by 2050. Thus, the vascular imaging systems market will accelerate at a CAGR of 5.7% during 2017–2023.

Additionally, healthcare facilities such as hospitals, diagnostic centers, and specialty clinics also deploy X-ray, magnetic resonance imaging (MRI), ultrasound, and nuclear imaging systems, including single-photon emission computed tomography (SPECT) and positron emission tomography (PET), to diagnose vascular diseases. The widescale deployment of these systems has encouraged medical device companies, such as Hitachi Ltd., Fujifilm Corporation, Siemens AG, Carestream Health, Canon Inc., General Electric Company, Carestream Health Inc., Esaote S.P.A, Koninklijke Philips N.V., and Shimazdu Corporation, to manufacture advanced variants and target more customers. According to P&S Intelligence, North America adopts the largest number of vascular imaging devices and equipment due to the growing awareness regarding imaging techniques in the region. Furthermore, the Asia-Pacific (APAC) vascular imaging systems market will exhibit the fastest growth in the foreseeable future owing to the surging incidence of CVDs and cancer. Moreover, European countries, including Germany, France, and the U.K., utilize a large number of vascular imaging products due to the increasing cases of life-threatening ailments. Thus, with the growing elderly population and escalating incidence of CVDs and cancer, the deployment of vascular imaging systems will soar in the foreseeable future.

The International Diabetes Federation’s (IDF) Diabetes Atlas Ninth edition 2019 reveals that 374 million individuals are at an increased risk of developing type 2 diabetes and over 1.1 million adolescents and children are living with type 1 diabetes globally. The IDF also forecasts that the number of diabetic patients aged 20–79 years will rise from 463 million in 2019 to 700 million by 2045. These people often suffer from chronic wounds, as diabetes hinders the rapid healing of wounds, thereby leading to the development of diabetic foot ulcers. Thus, the surging incidence of diabetic foot ulcers will help the negative pressure wound therapy devices market progress at a CAGR of 7.7% during 2020–2030. According to P&S Intelligence, the market revenue will grow from $2,248.1 million in 2020 to $4,698.4 million by 2030. Additionally, the rising cases of burns will also create a huge requirement for NPWT devices in the forthcoming years. As per the World Health Organization (WHO), approximately 180,000 burn-related deaths are recorded every year across the globe.

In recent years, NPWT device manufacturers have engaged in mergers and acquisitions to meet the needs of hospitals and home-care settings. For example, in April 2019, Lohmann & Rauscher GmbH & Co. KG acquired the assets of Médical Textile Ariégeois, a French compression company, to expand its compression product portfolio. Other medical device companies undertaking mergers and acquisitions include Alleva Medical Ltd., Medela AG, Carilex Medical GmbH, Baxter International Inc., DeRoyal Industries Inc., Cardinal Health Inc., and Shandong Weigao Xinsheng Medical Devices Co. Ltd. Furthermore, the Asia-Pacific (APAC) region is expected to adopt a substantial volume of NPWT devices in the foreseeable future, on account of the rising geriatric population, increasing number of traumatic wounds and burns, and booming population in the region. For instance, the Australian and New Zealand Burn Association (ANZBA) states that nearly 50,000 burn victims are admitted to hospitals in Australia each year. Similarly, the WHO estimates that over 1,000,000 individuals in India are severely or moderately burnt every year. Thus, the soaring cases of diabetes and burns will facilitate the adoption of NPWT devices in the upcoming years.

In North America, healthcare providers must regularly maintain their medical equipment due to the presence of a stringent regulatory framework. This is because medical equipment is used multiple times a day, which makes it prone to breaking down. For example, imaging systems, including endoscopes, ultrasound systems, and X-ray systems, are used in various clinical applications, and for enhancing their life and maintaining the accuracy of the results they provide, they require constant and proper maintenance.

Maintenance and calibration services also help in preventing the various infections caused due to the usage of unmaintained and unhygienic medical devices during surgeries and other procedures. Thus, the increasing emphasis on cleanliness in healthcare facilities will take the North American ISOs medical device and equipment maintenance and calibration services market from $1,468.8 million in 2019 to $3,612.9 million by 2030, at an 8.9% CAGR. Moreover, the World Health Organization has issued a few guidelines that focus on equipment maintenance, for controlling the spread of infections.

These and all other devices used in medical settings can be manual or automated, of which automated systems generate a higher demand for regular maintenance and calibration. It is ascribed to the government’s increasing financial support for healthcare automation. In addition, the continuous technological advancements in automation solutions and surging requirement for the reproducibility and accuracy of these devices are propelling their demand. Moreover, since automated devices are more complex than manual ones, healthcare providers choose to get them serviced by experts, rather than doing it in-house.

Hence, with 951 community hospitals owned by local and state governments and 207 hospitals owned by the Federal Government, the U.S. will continue to be the larger market for medical device and equipment maintenance and calibration services by ISOs in North America over this decade. According to P&S Intelligence, it will also be due to the presence of established medical device manufacturers and ISOs in the U.S. and rising technological advancements in diagnostic tests. Therefore, the rising awareness about preventing infections by maintaining medical devices is propelling the demand for regular maintenance and calibration of medical equipment in North America, which is being increasingly met by ISOs, instead of OEMs and hospitals’ in-house staff.